Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Ligand-independent signaling by overexpressed CD30 drives NF-κB activation in Hodgkin–Reed-Sternberg cells

Abstract

Overexpression of CD30 and constitutive NF-κB activation characterizes tumor cells of Hodgkin's disease (HD), Hodgkin and Reed-Sternberg (H–RS) cells. We report that in H–RS cells overexpression of CD30 leads to self-aggregation, recruitment of TRAF2 and TRAF5, and NF-κB activation, independent of CD30 ligand. CD30 and TRAF proteins co-localized in H–RS cell lines and in lymph nodes of HD. An adenovirus-vector carrying a decoy CD30 lacking the cytoplasmic region or a dominant negative IκBα mutant blocks NF-κB activation, down regulates IL-13 expression and induces apoptosis. Thus, in H–RS cells, ligand-independent activation of CD30 signaling drives NF-κB activation and this leads to constitutive cytokine expression, which provides a molecular basis for HD. Inhibition of NF-κB activation by adenovirus vector-mediated gene transfer may provide a novel strategy of cell- and target molecule-specific therapy for patients with HD.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Adam D, Kessler U, Kronke M . 1995 J. Biol. Chem. 270: 17482–17487

  • Aizawa S, Nakano H, Ishida T, Horie R, Nagai M, Ito K, Yagita H, Okumura K, Inoue J, Watanabe T . 1997 J. Biol. Chem. 272: 2042–2045

  • Andrews NC, Faller DV . 1991 Nucl. Acids Res. 19: 2499

  • Baker SJ, Reddy EP . 1998 Oncogene 17: 3261–3270

  • Baldwin Jr AS . 1996 Annu. Rev. Immunol. 14: 649–683

  • Bargou RC, Leng C, Krappmann D, Emmerich F, Mapara MY, Bommert K, Royer HD, Scheidereit C, Dürken B . 1996 Blood 87: 4340–4347

  • Bargou RC, Emmerich F, Krappmann D, Bommert K, Mapara MY, Arnold W, Royer HD, Grinstein E, Greiner A, Scheidereit C, Dürken B . 1997 J. Clin. Invest. 100: 2961–2969

  • Boldin MP, Mett IL, Varfolomeev EE, Chumakov I, Shemer-Avni Y, Camonis JH, Wallach D . 1995 J. Biol. Chem. 270: 387–391

  • Boucher L-M, Marengere LEM, Lu Y, Thurkral S, Mak TM . 1997 Biochem. Biophys. Res. Commun. 233: 592–600

  • Cabannes E, Khan G, Aillet F, Jarrett RF, Hay RT . 1999 Oncogene 18: 3063–3070

  • Cantwell MJ, Sharma S, Friedmann T, Kipps TJ . 1996 Blood 88: 4676–4683

  • Chan FK, Chun HJ, Zheng L, Siegel RM, Bui KL, Lenardo MJ . 2000 Science 288: 2351–2354

  • Cossman J, Annunziata CM, Barash S, Staudt L, Dillon P, He WW, Ricciardi-Castagnoli P, Rosen CA, Carter KC . 1999 Blood 94: 411–416

  • Duckett CS, Gedrich RW, Gilfillan MC, Thompson CB . 1997 Mol. Cell Biol. 17: 1535–1542

  • Duckett CS, Thompson CB . 1997 Genes Dev. 11: 2810–2821

  • Dürkop H, Latza U, Hummel M, Eitelbach F, Seed B, Stein H . 1992 Cell 68: 421–427

  • Emmerich F, Meiser M, Hummel M, Demel G, Foss HD, Jundt F, Mathas S, Krappmann D, Scheidereit C, Stein H, Dürken B . 1999 Blood 94: 3129–3134

  • Falini B, Pileri S, Pizzolo G, Dürkop H, Flenghi L, Stirpe F, Martelli MF, Stein H . 1995 Blood 85: 1–14

  • Gedrich RW, Gilfillan MC, Ducket CS, Van Dongen JL, Thompson CB . 1996 J. Biol. Chem. 271: 12852–12858

  • Grüss HJ, Boiani N, Williams DE, Armitage RJ, Smith CA, Goodwin RG . 1994 Blood 83: 2045–2056

  • Grüss HJ, Kadin ME . 1996 Baillieres Clin. Haematol. 9: 417–446

  • Harris NL . 1999 Semin. Hematol. 36: 220–232

  • Heinemeyer T, Wingender E, Reuter I, Hermjakob H, Kel AE, Kel OV, Ignatieva EV, Ananko EA, Podkolodnaya OA, Kolpakov FA, Podkolodny NL, Kolchanov NA . 1998 Nucleic Acids Res. 26: 362–367

  • Horie R, Ito K, Tatewaki M, Nagai M, Aizawa S, Higashihara M, Ishida T, Inoue J, Takizawa H, Watanabe T . 1996 Blood 88: 2422–2432

  • Horie R, Watanabe T . 1998 Semin. Immunol. 10: 457–470

  • Horie R, Aizawa S, Nagai M, Ito K, Higashihara M, Ishida T, Inoue J, Watanabe T . 1998 Int. Immunol. 10: 203–210

  • Hsu PL, Hsu SM . 2000 Lab. Invest. 80: 1111–1119

  • Josimovic-Alasevic O, Dürkop H, Schwarting R, Backe E, Stein H, Diamantstein T . 1989 Eur. J. Immunol. 19: 157–162

  • Kadin ME, Liebowitz DN . 1999 Hodgkin's disease Mauch PM, Armitage JO, Diehl V, Hoppe RT and Weiss LM (eds) Philadelphia: Lippincott Williams and Wilkins pp 139–157

    Google Scholar 

  • Kanegae Y, Tavares AT, Izpisua Belmonte JC, Verma IM . 1998 Nature 392: 611–614

  • Kanzler H, Kuppers R, Hansmann ML, Rajewsky K . 1996 J. Exp. Med. 184: 1495–1505

  • Kapp U, Yeh WC, Patterson B, Elia AJ, Kagi D, Ho A, Hessel A, Tipsword M, Williams A, Mirtsos C, Itie A, Moyle M, Mak TW . 1999 J. Exp. Med. 189: 1939–1946

  • Krappmann D, Emmerich F, Kordes U, Scharschmidt E, Dürken B, Scheidereit C . 1999 Oncogene 18: 943–953

  • Kuppers R, Rajewsky K, Zhao M, Laumann G, Simons R, Fischer R, Hansmann ML . 1994 Proc. Natl. Acad. Sci. USA 91: 10962–10966

  • Lee SY, Lee SY, Kandala G, Liou M-L, Choi Y . 1996 Proc. Natl. Acad. Sci. USA 93: 9699–9703

  • Marafioti T, Hummel M, Foss HD, Laumen H, Korbjuhn P, Anagnostopoulos I, Lammert H, Demel G, Theil J, Wirth T, Stein H . 2000 Blood 95: 1443–1450

  • Medina D, Sheay W, Goodell L, Kidd P, White E, Rabson AB, Strair RK . 1999 Blood 94: 3499–3508

  • Miyake S, Makimura M, Kanegae Y, Harada S, Sato Y, Takamori K, Tokuda C, Saito I . 1996 Proc. Natl. Acad. Sci. USA 93: 1320–1324

  • Pan G, Ni J, Wei YF, Yu J, Gentz R, Dixit VM . 1997 Science 277: 815–818

  • Papoff G, Hausler P, Eramo A, Pagano MG, Leve GD, Signore A, Ruberti G . 1999 J. Biol. Chem. 274: 38241–38250

  • Pinto A, Aldinucci D, Gloghini A, Zagonel V, Degan M, Improta S, Juzbasic S, Todesco M, Perin V, Gattei V, Herrmann F, Gruss HJ, Carbone A . 1996 Blood 88: 3299–3305

  • Prince HM, Dessureault S, Gallinger S, Krajden M, Sutherland DR, Addison C, Zhang Y, Graham FL, Stewart AK . 1998 Exp. Hematol. 26: 27–36

  • Schwab U, Stein H, Gerdes J, Lemke H, Kirchner H, Schaadt M, Diehl V . 1982 Nature 299: 65–67

  • Sheridan JP, Marsters SA, Pitti RM, Gurney A, Skubatch M, Baldwin D, Ramakrishnan L, Gray CL, Baker K, Wood WI, Goddard AD, Godowski P, Ashkenazi A . 1997 Science 277: 818–821

  • Siegel RM, Frederiksen JK, Zacharias DA, Chan FK, Johnson M, Lynch D, Tsien RY, Lenardo MJ . 2000 Science 288: 2354–2357

  • Smith CA, Grüss HJ, Davis T, Anderson D, Farrah T, Baker E, Sutherland GR, Brannan CI, Copeland NG, Jenkins NA, Grabstein KH, Gliniak B, McAlister IB, Fanslow W, Alderson M, Falk B, Gimpel S, Gillis S, Din WS, Goodwin RG, Armitage RJ . 1993 Cell 73: 1349–1360

  • Smith CA, Farrah T, Goodwin RG . 1994 Cell 76: 959–962

  • Song HY, Dunbar JD, Donner DB . 1994 J. Biol. Chem. 269: 22492–22495

  • Teoh G, Chen L, Urashima M, Tai YT, Celi LA, Chen D, Chauhan D, Ogata A, Finberg RW, Webb IJ, Kufe DW, Anderson KC . 1998 Blood 92: 4591–4601

  • Vandevoorde V, Haegeman G, Fiers W . 1997 J. Cell Biol. 137: 1627–1638

  • von Wasielewski R, Seth S, Franklin J, Fischer R, Hubner K, Hansmann ML, Diehl V, Georgii A . 2000 Blood 95: 1207–1213

  • Wood KM, Roff M, Hay RT . 1998 Oncogene 16: 2131–2139

  • Wu MY, Wang PY, Han SH, Hsieh SL . 1999 J. Biol. Chem. 274: 11868–11873

Download references

Acknowledgements

This work was supported in part by a Grant in Aid for Scientific Research and a Grant in Aid for Cancer Research from the Ministry of Education, Science, Technology, Sports and Culture, Japan, to T Watanabe, and by The Mochida Memorial Foundation for Medical and Pharmaceutical Research to R Horie. We thank M Ohara for comments on the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Takuro Watanabe.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Horie, R., Watanabe, T., Morishita, Y. et al. Ligand-independent signaling by overexpressed CD30 drives NF-κB activation in Hodgkin–Reed-Sternberg cells. Oncogene 21, 2493–2503 (2002). https://doi.org/10.1038/sj.onc.1205337

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205337

Keywords

This article is cited by

Search

Quick links